ALNY vs RPD · P/E 76, rev $1.29B vs P/E 59, rev $420.6M
Alnylam Pharmaceuticals Inc (ALNY) versus Rapid7 Inc (RPD) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Rapid7 Inc (RPD) is a software - infrastructure company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported RPD revenue for 2026-06-30 was $420.6M. Net income was $7.2M. RPD currently screens at market cap $1.57B and trailing P/E 59.4.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. RPD currently screens at market cap $1.57B and trailing P/E 59.4.
Not investment advice. Open the ALNY and RPD stock pages for the full models.
Not investment advice.